The Effect of Low Dose Ketamine on Narcotic Consumption in Patients Undergoing Laparoscopic Cholecystectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05444777

Enrollment

Registered

2022-07-06

Start date

2013-01-17

Completion date

2013-11-30

Last updated

2023-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis

Brief summary

This double-blinded randomized control trial aims to analyze the effect of low dose Ketamine on narcotic consumption, in patients undergoing Laparoscopic cholecystectomy.

Interventions

DRUGKetamine Hydrochloride

Ketamine was given prior to wound closure.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double blinded

Intervention model description

Randomized control trial

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* all ASA 1 and 2 patients undergoing Laparoscopic Cholecystectomy electively.

Exclusion criteria

* Hepatic and renal disease and ASA 3 and 4 patients.

Design outcomes

Primary

Measure	Time frame	Description
pain score using Visual Analogue scale, ranging from 0 (minimum) and 10 (maximum), 3 and below showing no pain and scores above 3 showing moderate to severe pain.	Baseline on arrival in the post anaesthesia care unit and then every fifteen minutes unto one hour	Change in pain score using Visual Analogue Scale

Secondary

Measure	Time frame	Description
narcotic consumption in the post operative anaesthesia care unit	postoperatively, after arrival in the post anaesthesia care unit at every fifteen minutes unto one hour	requirement of narcotic in the post anaesthesia care unit

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026